Introduction
TB, death, viral suppression
COVID-19 (CORONAVIRUS DISEASE 2019), TUBERCULOSIS, TUBERCULOSIS (TB)
Tuberculosis (TB) overtook HIV as the leading infectious cause of death worldwide, prior to the Coronavirus Disease 2019 (COVID-19) pandemic, requiring a major policy shift if it is to be controlled in line with the global commitment to “end TB” [Meanwhile, 4 community-randomised trials have shown that delivery of universal HIV testing, and universal ART for HIV–positive individuals (universal testing and treatment, UTT), achieves high ART coverage and viral suppression among HIV–positive individuals [The HIV Prevention Trials Network (HPTN) 071 (PopART) community-randomised trial was conducted during 2013 to 2018 in 21 communities in Zambia and the Western Cape Province of South Africa and was designed to measure the impact of a combination HIV prevention package (the PopART intervention) on HIV incidence [To contribute to the evidence base on how to reduce TB burden in HIV-endemic settings, the TREATS (Tuberculosis Reduction through Expanded Anti-retroviral Treatment and Screening) study was designed to measure the population-level impact of the PopART intervention on TB prevalence, transmission, and TB notifications. We report here on the impact of the PopART intervention on TB prevalence; this was measured during 2019 to 2021, 2 to 4 years after the last year of the PopART intervention delivery.